Rafik Hariri University Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Crohn's disease2 trials
• Lung cancer1 trial
• Ulcerative colitis1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• EMD Serono Research & Development Institute, Inc.1 trial
• Janssen Research & Development, LLC1 trial
• Shire1 trial

Running trials

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· Phase 3· Shire· Source

• Completed

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· Phase 3· EMD Serono Research & Development Institute, Inc.· Source